Search Results - "Sanmamed, N.S."

Quality of Life in Patients Enrolled in a Randomized Clinical Trial Evaluating Hypofractionated Radiotherapy for Intermediate Risk Prostate Cancer by Sanmamed, N.S., Chung, P., Dayes, I., Liu, A., Catton, C.N., Wright, J., Martin, J.M.

“…The PROFIT study was designed to evaluate hypofractionated (HF) radiotherapy versus conventional fractionation (CF) for patients with intermediate-risk…”
Get full text

Low Dose Radiotherapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19): Final Results by Sanmamed, N.S., Alcantara, P., Cerezo, E., Gaztanaga, M., Doval, A., Corona, J., Gomez, S., Bustos, A., Rodriguez, G., Fuentes, M., Sanz, A., Vazquez, G.

Get full text

Low Dose Radiotherapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19) by Sanmamed, N.S., Alcantara, P., Cerezo, E., Gaztanaga, M., Doval, A., Corona, J., Gomez, S., Bustos, A., Cabello, N., Lopez, A., Fuentes, M., Sanz, A., Vazquez, G.

“…To evaluate the safety and efficacy of Low-Dose Radiation (LD-RT) to treat COVID-19 pneumonia. We conducted a prospective phase I-II trial enrolling patients ≥…”
Get full text

Use of Combined Hormone Therapy with Post-Operative Radiation Treatment for Prostate Cancer: Impact of Randomized Trials On Clinical Practice by Sanmamed, N.S., Glicksman, R., Heaton, J., Herrera-Caceres, J., Joseph, L., Hansen, A., Chung, P., Finelli, A., Fleshner, N.E., Berlin, A.

Get full text

Preliminary Results Of MR-Guided Brachytherapy Boost To External Beam Radiotherapy For Intermediate And High Risk Prostate Cancer by Fong, C.H., Padayachee, J., Liu, Z., Weiss, J., Lao, B., Gumapac, N., Bettoli, P., Sanmamed, N.S., Rink, A., Weersink, R.A., Bayley, A., Raman, S., Helou, J., Catton, C., Warde, P., Berlin, A., Menard, C., Chung, P.

Get full text